The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vamsi Krishna Potluri & PACs
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Promoter Vamsi Krishna Potluri along with Persons Acting in Concert (PACs) have converted 50,00,000 warrants into equal number of equity shares of SMS Pharmaceuticals on September 10, 2025 via preferential allotment. Vamsi Krishna Potluri received 25,00,000 equity shares (2.82% of capital) and Trilok Potluri received another 25,00,000 shares (2.82%). As a result, the promoter group's voting shareholding rose from 41.35% to 46.99% of paid-up capital, while the total promoter group holding (including encumbered shares) remains at 71.90%. The company's total equity share capital increased from ₹8.87 crore to ₹9.37 crore, comprising 9,36,52,030 shares of ₹1 each.
This is a confidence signal from promoters as they are converting existing warrants into equity, which increases their direct voting stake and signals long-term commitment to the company. Total promoter ownership stays high at nearly 72%, reducing free float, but no fresh dilution risk remains since warrants were pre-existing. Neutral to mildly positive for shareholders as it shows promoter belief in the company's value.